CDs as solubilizers: Effects of excipients and competing drugs

被引:85
作者
Jansook, Phatsawee [1 ]
Loftsson, Thorsteinn [1 ]
机构
[1] Univ Iceland, Fac Pharmaceut Sci, IS-107 Reykjavik, Iceland
关键词
Cyclodextrins; Formulation; Solubility; Aggregates; Permeation; Availability; CYCLODEXTRINS; COMPLEXATION; INDOMETHACIN;
D O I
10.1016/j.ijpharm.2009.06.005
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
In recent years cycloclextrins (CDs) have been acknowledged by the pharmaceutical industry as very useful enabling excipients for solubilization and stabilization of drugs in aqueous formulations. Their effect is however strongly influenced by other commonly used excipients. The purpose of this investigation was to examine the effects of excipients and drug combinations on the effects of CD solubilization of drugs and drug availability. The model drug was dexamethasone, the competing drugs tested were hydrocortisone, indomethacin and amphotericin B, and the sample CDs were gamma-cyclodextrin (gamma CD) and 2-hydroxypropyl-gamma-cyclodextrin (HP gamma CD). Benzalkonium chloride and hydroxypropyl rnethylcellulose enhance the solubilizing effect of the CDs whereas in general EDTA decreased the effect. The effect of second drug present in the aqueous formulation did depend on the affinity of that drug for the CD. Drugs which readily formed complexes with the CDs (e.g. hydrocortisone) decreased their ability to solubilize dexamethasone. Drugs that have little affinity for CDs (e.g. amphotericin B) did in some cases improve the CD solubilization of dexamethasone. Flux diagrams obtained through semi-permeable cellophane membrane indicated that drug/CD complexes self-assemble to form aggregates, especially at CD concentrations above 5% (w/v). This aggregate formation was affected by the excipients and did influence drug availability from the formulations. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:32 / 40
页数:9
相关论文
共 22 条
[1]
[Anonymous], 1965, Advances in Analytical Chemistry and Instrumentation
[2]
Cyclodextrins as pharmaccutical solubilizers [J].
Brewster, Marcus E. ;
Loftsson, Thorsteinn .
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (07) :645-666
[3]
Influence of hydrophilic polymers on celecoxib complexation with hydroxypropyl β-cyclodextrin [J].
Chowdary, Kora Pattabhi Ramaiah ;
Srinivas, Sekuboyina Vijaya .
AAPS PHARMSCITECH, 2006, 7 (03) :E1-E6
[4]
Preparation of amorphous indomethacin from aqueous 2,6-di-O-methyl-β-cyclodextrin solution [J].
Iohara, Daisuke ;
Hirayama, Fumitoshi ;
Ishiguro, Takako ;
Arima, Hidetoshi ;
Uekama, Kaneto .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 354 (1-2) :70-76
[5]
JANSOOK P, J PHARM SCI IN PRESS
[6]
γCD/HPγCD: Synergistic solubilization [J].
Jansook, Phatsawee ;
Loftsson, Thorsteinn .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 363 (1-2) :217-219
[7]
Hydroxypropyl-β-cyclodextrin and its combination with hydroxypropyl-methylcellulose increases aqueous solubility of Δ9-tetrahydrocannabinol [J].
Jarho, P ;
Pate, DW ;
Brenneisen, R ;
Järvinen, T .
LIFE SCIENCES, 1998, 63 (26) :PL381-PL384
[8]
KANENIWA N, 1985, CHEM PHARM BULL, V33, P3447
[9]
Kristinsson JK, 1996, INVEST OPHTH VIS SCI, V37, P1199
[10]
The effect of fatty acid substitution on the in vitro release of amphotericin B from micelles composed of poly(ethylene oxide)-block-poly(N-hexyl stearate-L-aspartamide) [J].
Lavasanifar, A ;
Samuel, J ;
Kwon, GS .
JOURNAL OF CONTROLLED RELEASE, 2002, 79 (1-3) :165-172